Centessa Pharmaceuticals plc ($CNTA)
Filing Information
| Accession Number | 0001470831-26-000092 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
267,741
Total Value
$1,196,072.21
P&L
+inf% (+$5,953,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Ordinary Shares | โ | Jan 30, 2026 | Sale | 1,010 | $25.01 | $25,261.01 | 104,376 | Direct | โ | View Details | |
Chief Legal Officer | Ordinary Shares | โ | Feb 1, 2026 | Tax Withholding | 7,780 | $24.57 | $191,154.60 | 96,596 | Direct | โ | View Details | |
Chief Legal Officer | Ordinary Shares | โ | Feb 2, 2026 | Sale | 38,951 | $25.15 | $979,656.60 | 57,645 | Direct | โ | View Details | |
Chief Legal Officer | Ordinary Shares | โ | Feb 2, 2026 | Grant/Award | 40,000 | $0.00 | $0.00 | 97,645 | Direct | โ | View Details | |
Chief Legal Officer | Ordinary Shares | โ | Feb 2, 2026 | Grant/Award | 20,000 | $0.00 | $0.00 | 117,645 | Direct | โ | View Details | |
Chief Legal Officer | Share Option (right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 160,000 | $0.00 | $0.00 | 160,000 | Direct | โ | View Details |